Delivery Order SPE2DR25D3103-SPE2DR26F9J71
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,004.52 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials. This competitively awarded, firm fixed-price contract was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $32,686.40 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 1 mg/dose in 3 mL vials on September 19, 2025, with completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $45,553.12 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) injectable medication on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under...
- The Defense Logistics Agency awarded a $26,158.82 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL vials, with performance completion targeted for December 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,793.77 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 1 mg/dose in 3 ml vials. This firm fixed-price delivery order, issued on October 24, 2025, with completion expected by October 27, 2025, represents a non-competitive contract award. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $2,506.64 delivery order to AmerisourceBergen Drug Corp for Ozempic (semaglutide) 1 mg/dose in 3 mL vials on June 27, 2025, with completion targeted for June 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $32,921.36 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems. The delivery order...
- The Defense Logistics Agency awarded a $11,296.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with an ultimate completion date of October 16, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $18,198.96 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials. The contract was competitively awarded with firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,361.80 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitive award uses firm fixed pricing with no set-aside designation and is scheduled for completion by August 12, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9J71Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,706.54 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 1 mg/dose in 3 mL vial format on November 26, 2025, with completion targeted for November 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion master vehicle running through December 2026 that establishes the company as a pharmaceutical prime vendor for global military healthcare support. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare systems, with an extensive portfolio spanning specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle enables flexible procurement of pharmaceutical commodities to support military personnel and healthcare programs worldwide. This particular delivery order for Ozempic, a diabetes medication widely utilized in military healthcare systems, reflects the company's ongoing role in supplying essential pharmaceutical products through the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 11/25/25 |